TCM
PHIO icon

Tang Capital Management’s Phio Pharmaceuticals PHIO Stock Holding History

Tang Capital Management’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3
Closed -$1.13M – 8
2015
Q1 		$1.13M Buy
+3
New +$2.13M 0.6% 8
2014
Q4 		– Hold
0
– -$100K – 10
2014
Q3 		– Hold
0
– – – 10
2014
Q2 		– Hold
0
– -$78K – 13
2014
Q1 		– Hold
0
– – – 12

Other funds holding PHIO

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BW
Bison Wealth Atlanta, Georgia $454M AUM 22.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PSUF
People's United Financial Bridgeport, Connecticut $3.51B AUM 12.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tang Capital Management's PHIO Position: Q2 2015 in Review

Tang Capital Management sold out of Phio Pharmaceuticals (PHIO) in Q2 2015, closing a stake of 3 shares — an estimated $1.13M sold.

Tang Capital Management first reported a position in PHIO in Q1 2015 and held it in 1 quarter. The position peaked at $1.13M in Q1 2015. 3 funds tracked by Wall St. Rank hold PHIO as of Q2 2015.

  • Tang Capital Management reported no remaining Phio Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Tang Capital Management sold 3 Phio Pharmaceuticals shares in Q2 2015, an estimated $1.13M.
  • Tang Capital Management first reported a position in Phio Pharmaceuticals in Q1 2015 and held it in 1 quarter.
  • Tang Capital Management's Phio Pharmaceuticals position peaked at $1.13M in Q1 2015.
  • 3 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2015.

Based on Tang Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.